Skip to content
The Nexus
DossierENTITY

VRTX

Coverage of VRTX in the Nexus archive.

Earliest in view: Aug 3 · 20:12 UTCMost recent: Aug 3 · 20:12 UTC
Co-mentioned in this coverage
Vertex Pharmaceuticalsorganization1Zacks Investment Researchorganization1Associated Pressorganization1
Recent coverage
  • BUSINESSAug 3 · 20:12 UTCWTOP DC
    Vertex: Q2 Earnings Snapshot

    Vertex Pharmaceuticals reported second-quarter profit of $1.1 billion with $4.31 per-share net income, adjusted to $4.73, below Wall Street's $4.79 estimate. Revenue of $3.33 billion exceeded forecasts, and the company projects full-year revenue between $13.1 billion and $13.2 billion.

VRTX · Dossier · The Nexus